|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immunology |
The Neuromuscular Research Group, The University of Otago, Dunedin, New Zealand
| ABSTRACT |
|---|
|
|
|---|
conceptus, cytokines, growth factors, immunology, pregnancy
| INTRODUCTION |
|---|
|
|
|---|
Immune rejection in the adult is regulated by complex interactions involving multiple cytokines. These interactions are also likely to be important in pregnancy, with successful pregnancy being dependent on an appropriate balance of cytokines at the maternal-fetal interface. T-helper (Th) 2/3-type cytokines, such as the transforming growth factor-betas (TGFßs), interleukin-10 (IL-10), and colony- stimulating factor-1 (CSF-1), appear to promote pregnancy whereas proinflammatory Th1 cytokines, such as tumor necrosis factor-
and IL-2, are detrimental [35].
The TGFßs are a small family of proteins with three mammalian members, all of which are potent regulators of the immune system. In most circumstances, the TGFßs suppress the activities of immune cells [6]. The three TGFß isoforms are present in the uterus [7, 8] and concepti [9], but have distinct spatial and temporal patterns. TGFß2 is produced by the placenta [7, 10] and has been implicated in creating immune tolerance of the placenta [5]. The distribution of TGFß2 within the fetus is, however, comparatively limited [11], making it unlikely that it is primarily responsible for suppressing immune cells that pass through the placenta. TGFß1 is a better candidate for this role, as it is ubiquitously present in fetal tissues [12, 13]. TGFß1 could also be important for maintenance of the placenta, as decidual cells produce TGFß1, as well as TGFß2 [7, 8].
The phenotype of TGFß1/ mice is complex and varies with genetic background [14, 15], but to date, there have been no reports of maternal rejection of TGFß1-deficient concepti (fetus plus extraembryonic membranes). However, all of the TGFß1-deficient colonies studied have inbred background that limits the immunological distinction between the mother and her fetuses. We have therefore undertaken a retrospective examination of the breeding records of an inbred and an outbred colony of TGFß1+/ mice, seeking evidence of maternal rejection of fetuses.
As a result of the limited exchange of material between the mother and her conceptus, immune-related conditions such as Rh hemolytic disease are rare during a first pregnancy [16]. This provides a means to assess the physiological role of cytokines in preventing immune-mediated abortion. Simply, if TGFß1 prevents immune rejection of fetuses in vivo, then the loss of TGFß1-deficient fetuses should increase with the parity (number of pregnancies) of their mother. We report here that the loss of TGFß1/ and TGFß1+/ fetuses in outbred mice follows this pattern.
| MATERIALS AND METHODS |
|---|
|
|
|---|
All experiments were approved by The University of Otago's Animal Ethics Committee. The majority of the mice were originally bred for experiments that are unrelated to the present study [17, 18].
Swiss Webster mice were obtained from the University of Otago's colony.
The inbred TGFß1+/ colony was a derivative of Prof. T. Doetschman's [14] and was established with mice purchased from The Jackson Laboratory (Bar Harbor, ME). These mice had a mixed 129/Sv x C57BL/6J background. The colony was maintained by mating TGFß1+/ studs and dams. The genotypes of the mice were determined by polymerase chain reaction, as previously described [17].
The nude (Whn/) TGFß1/ colony was maintained by breeding Whn+/, TGFß1+/ dams with Whn/, TGFß1+/ studs and are referred to as outbred/nu. The mothers therefore produced T cells and TGFß1. The founder nude TGFß1+/ mice were generated by breeding TGFß1+/ dams with nude (Whn/) studs. The nude mice had an outbred Swiss Webster background (Crl:CD-1nuBR) and were from a local colony, ex Charles River Laboratories (Wilmington, MA). Nude dams were periodically introduced to the colony to maintain its outbred character.
Timed pregnancies were generated by mating TGFß1+/ males and females at 1700 h. The females were examined the following morning at 0700 h for the presence of copulatory plugs. The males were removed to prevent copulation during the daytime. Noon on the day of detection of a plug was defined as E0.5.
An outbred/wt colony was established by crossing inbred TGFß1+/ studs with Swiss Webster dams. The male TGFß1+/ pups resulting from these crosses were then crossed with Swiss Webster dams. The F2 TGFß1+/ dams and studs were mated to analyze the survival of TGFß1+/ fetuses in outbred Swiss Webster mice, lacking the nude mutation.
Collection of Amniotic Fluid
Pregnant dams were anesthetized with pentobarbitone and their abdomens opened. The amniotic fluid of each conceptus was collected by inserting a syringe with a 16-gauge needle through the chorion and amnion. The amniotic fluid was centrifuged at 12 000 x g for 5 min at 4°C to remove cells and immediately snap frozen in liquid nitrogen. The samples were stored at 80°C. The tail of each fetus was collected and used for genotyping [17].
Collection of Platelet-Deficient Plasma
Platelet-deficient plasma was prepared using a standard technique. Mice were anesthetized with diethyl ether and 400 µl of their blood removed by cardiac puncture using a syringe and 16-gauge needle that had been washed with 2% EDTA. The blood was added to a tube containing 40 µl of 2% EDTA at 4°C and then spun at 12 000 x g for 15 min at 4°C.
ELISA
The concentrations of TGFß1 in amniotic fluid and plasma were measured using the Promega Emax Immunoassay system (Promega, Madison, WI) according to the manufacturer's instructions. Each sample was acidified with HCl to a pH of 1.6 for 15 min, neutralized with NaOH, and diluted with the manufacturer's sample buffer to ensure that all measurements were made in the middle of the range of the ELISA (311000 pg/ ml). The intraassay variation was 7.7%. The ELISA was specific to TGFß1, with a cross-reactivity of less than 5% with TGFß2 and TGFß3 at 10 ng/ml (Promega).
| RESULTS |
|---|
|
|
|---|
Retrospective analysis of the breeding records of two colonies of TGFß1+/ mice was undertaken to assess whether the loss of TGFß1-deficient fetuses was related to parity. The frequency of TGFß1/ mice surviving to birth in the outbred/nu colony was strongly linked to parity. The loss of TGFß1/ concepti increased substantially after the first pregnancy, with no mutants surviving in mothers carrying their third or subsequent pregnancy (Fig. 1). The survival of TGFß1/ concepti was not related to the age of the mother, indicating that the association with parity was not an indirect consequence of mothers being young during their first pregnancy.
|
We then examined whether experienced outbred/nu mothers rejected a proportion of their wild-type and heterozygous concepti, along with the mutants. The number of wild-type pups per litter averaged 3.3 and was not correlated with parity (not illustrated). The expected ratio of heterozygous to wild-type concepti is two, which was observed in the litter from monoparous mothers. The ratio with experienced mothers (two or more pregnancies) was 1.5, which is significantly less than expected (P < 0.01, chi-squared). The extent of this loss was maximal with the second litter and relatively constant thereafter (Fig. 2). This suggests that experienced outbred/nu mothers reject approximately one in four of their TGFß1+/ concepti.
|
TGFß1/ concepti were also lost in the inbred colony (Table 1). However, in marked contrast with the outbred/ nu colony, the extent of this loss was unrelated to parity, with mothers able to carry a proportion of their TGFß1/ embryos to term, even after 11 pregnancies (Table 1). The ratio of heterozygous to wild-type pups was also normal in the inbred colony for all parities (Table 1).
|
Inbred TGFß1+/ were then bred to Swiss Webster mice to produce an outbred TGFß1+/ colony that is wild type for the nude mutation (outbred/wt, colony). The number of mutant pups in this colony was also strongly linked to parity (Fig. 3), indicating that the Swiss Webster background is sufficient for the loss of TGFß1-deficient concepti to occur.
|
Maternal TGFß1 Is Present in Concepti
The amount of maternal TGFß1 in concepti was assessed by comparing the levels of TGFß1 protein in the amniotic fluids of TGFß1+/+, TGFß1+/, and TGFß1/ fetuses within a common TGFß1+/ mother (see Table 2). The concentration of TGFß1 in the amniotic fluids of the mutant fetuses was approximately half that of their wild- type littermates (Fig. 4B), indicating that significant maternal transfer of TGFß1 protein had occurred. Heterozygotic concepti had TGFß1 levels that were intermediate between their mutant and wild-type littermates (Fig. 4B). A gene dose relationship was also observed for the concentration of TGFß1 in maternal plasma (Fig. 4A).
|
|
Plasma TGFß1 Is Constant During Pregnancy
The concentration of TGFß1 in the plasma of humans rises during pregnancy [19]. In contrast with this, the level of TGFß1 in the TGFß1+/ dams used in the present study was not different from that of their nonpregnant counterparts (Fig. 4A). The possibility that maternal TGFß1 levels fluctuate during pregnancy was then further examined using Swiss Webster mice. No significant variation in plasma TGFß1 was observed at any stage of pregnancy (Fig. 5).
|
| DISCUSSION |
|---|
|
|
|---|
The frequency of TGFß1/ and TGFß1+/ mice surviving to birth was strongly linked to parity in the outbred/nu colony. This phenomenon was also observed in the outbred/ wt colony, indicating that the presence of the nude (Whn/) mutation is not essential for parity-related loss of concepti.
The loss of TGFß1-deficient concepti in the outbred colonies was not associated with maternal age, indicating that the association with parity is not an indirect consequence of more experienced mothers being older. Parity-related reproductive failure is rare and is usually indicative of the involvement of the maternal immune system. With the present study, this is particularly likely, as the fetuses being lost are deficient in a potent suppressor of immune responses.
The loss of TGFß1/ concepti in the inbred line was unrelated to parity. Several factors may combine here to create this phenomenon. First, the capacity of the inbred mothers to mount an immune attack against their concepti may be very limited. In inbred lines, the mother and her fetuses are genetically similar, which may attenuate (but not abolish) the ability of the mother to recognize her fetuses as foreign. Additionally, the inbred mice analyzed in this study had C57BL/6 ancestry, which can lead to diminished immune responses in some circumstances [20, 21] (see also www.informatics.jax.org/external/festing/search_form.cgi).
Second, the inbred mice had higher plasma levels of TGFß1 than outbred mice (cf., Figs. 4A and 5), which may make the survival of their offspring less dependent on fetal sources of TGFß1 (see below). Last, successful pregnancy is likely to depend on multiple genes, which may be differentially expressed in the inbred and outbred mice. This could lead to different strains of mice having different dependencies on TGFß1 (see below).
Loss of TGFß1-Deficient Concepti in Monoparous Mother
Some TGFß1/ concepti die early in development due to inadequate development of the yolk sac [14, 22]. The variability of this early death is due to allelic variation in a region of chromosome 5: TGFß1/ concepti survive when the chromosome is from NIH/Ola or 129 mice but not when it is from C57BL/6 mice [15, 23]. The inbred colony analyzed in this study had a mixed C57BL/6 x 129 background. The loss of TGFß1/ concepti that occurred in the inbred colony is thus probably due to the selective elimination of the mice with the unfavorable C57BL/6 allele. The loss of TGFß1/ concepti in the monoparous outbred mothers is suggestive that the unfavorable C57BL/ 6 allele is common in outbred colonies. However, we do not discount the possibility that immune rejection may also contribute to the loss of TGFß1/ concepti in monoparous outbred litters.
Dual Sources of TGFß1
The TGFß1 in amniotic fluid was observed to be of dual maternal and fetal origins. Amniotic fluid is a mixture of fetal urine and lung secretions [24]. The presence of maternal TGFß1 within the amniotic fluid is thus indicative that maternal TGFß1 passes through the fetus. Consistent with this, TGFß1 protein is bound to the connective tissues of TGFß1 null mutant concepti [18, 25] and intact iodinated TGFß1 is recoverable from fetuses after injection into the mother [25]. Thus, all fetal tissues appear to be bathed in TGFß1 from both the mother and from sources within the fetus (see [26] for the locations of fetal TGFß1 mRNA).
In the inbred line, the amniotic fluid from TGFß1 mutant fetuses had half the level of TGFß1 protein of their wild- type equivalents (see Fig. 4B and Table 2). This implies that the amniotic fluid from the wild-type concepti contained very similar amounts of maternal and fetal TGFß1. This method may, however, underestimate the maternal contribution, as the dams used in this study were TGFß1+/, which have half the wild-type levels of plasma TGFß1 (Fig. 4A). Thus, in wild-type pregnancies, the amount of maternal TGFß1 in a conceptus may be up to twice that of fetal TGFß1. However, we do not favor too exact a ratio being placed on the relative levels of maternal and fetal TGFß1, as the level of plasma TGFß1 varied with genetic background (cf. Figs. 4 and 5). As a conceptus is genetically different from its mother, it is likely that the ratio of maternal to fetal TGFß1 varies in a natural population. The importance of our observations is that they show that a conceptus has biologically significant amounts of TGFß1 from both its mother and itself.
Are Maternal and Fetal TGFß1 Redundant?
The existence of two sources of TGFß1 raises the issue of whether both are essential for the maintenance of pregnancy. When considering this question, it is important to bear in mind the following. TGFß-dependent phenomena exhibit different dose sensitivities. Mice that are heterozygous null for one of the TGFßs exhibit specific defects, even though they contain 50% of the normal levels of the TGFß [27, 28]. Other defects are only observed when both alleles are mutated [14, 29] (Table 1). Here, 50% of the normal levels of TGFß are sufficient for full function. Further defects emerge when deficiencies in TGFß signaling occur in concert with either deficiencies in other signaling pathways [30, 31] or allelic variations in genes with no obvious relationship to signaling pathways [32]. Consequently, we need to consider the possibilities that 1) maternal and fetal TGFß1 may jointly regulate some aspects of pregnancy/development while independently controlling other aspects and 2) the importance of TGFß1 in controlling immune rejection may be modulated by multiple factors, including the genetic backgrounds of both the mother and her concepti, the immunological similarity between the mother and her concepti, and the immune history of the mother.
With inbred mice, the mothers have high levels of plasma TGFß1 and no parity-related loss of TGFß1-deficient concepti occurs (this study). This indicates that fetal TGFß1 is not essential to prevent parity-related loss of concepti in this colony. This mirrors the situation with inbred neonates where maternal transfer of TGFß1 via milk is sufficient to suppress autoimmune attack in TGFß1/ pups [14, 33]. Both of these phenomena are, however, in marked contrast with the TGFß1-dependent development of the yolk sac, which appears to be entirely under the control of fetal TGFß1 [32, 34]. This is not surprising, as the defect in the yolk sac is lethal before extensive development of the placenta has occurred. The ability of maternal TGFß1 to reach the concepti would thus be limited.
The situation with the inbred mice also contrasts with that of the multiparous outbred mothers where fetal TGFß1 production is an important determinant of survival: wild- type concepti survive; TGFß1+/ concepti have reduced survival; TGFß1/ concepti do not survive, even though their amniotic fluids contain approximately 50% of TGFß1 of the wild-type littermates. This suggests that the TGFß1- dependent suppression of parity-related loss of concepti only occurs if the level of TGFß1 exceeds a threshold, as in the deficits observed in TGFß1+/ adults [27].
In summary, the data reported here show that concepti are exposed to significant levels of both fetal and maternal TGFß1. The levels of fetal TGFß1 appear to be a determinant of whether a conceptus is rejected or not, although the evidence clearly indicates that maternal TGFß1 and other factors are also important. In at least some circumstances, these factors may be sufficient to fully compensate for a low level of fetal TGFß1.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Correspondence: Ian S. McLennan, Department of Anatomy and Structural Biology, The University of Otago, P.O. Box 913, Dunedin, New Zealand. FAX: 64 3 479 7254; ian.mclennan{at}stonebow.otago.ac.nz ![]()
Received: 3 December 2003.
First decision: 6 January 2004.
Accepted: 28 January 2004.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
W. V. Ingman, R. L. Robker, K. Woittiez, and S. A. Robertson Null Mutation in Transforming Growth Factor {beta}1 Disrupts Ovarian Function and Causes Oocyte Incompetence and Early Embryo Arrest Endocrinology, February 1, 2006; 147(2): 835 - 845. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |